BioCorRx Inc. (BICX)
About BioCorRx Inc.
BIOCORRX INC NEW
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $797.2K
- Net income
- -$3.4M
- Total assets
- $2.1M
Source: SEC EDGAR · updated Jun 7, 2026
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
BioCorRx Inc. (BICX) Stock Price
- Reported a net loss of $3.4M in FY2025.
- Trading 40% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review BioCorRx Inc..
Write a review
BioCorRx Inc.: frequently asked questions
Is BioCorRx Inc. an American company?
BioCorRx Inc. is a US-based company headquartered in Anaheim, California, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is BioCorRx Inc. headquartered?
BioCorRx Inc. is headquartered in Anaheim, California, United States.
Is BioCorRx Inc. publicly traded?
Yes — BioCorRx Inc. is a publicly traded company. Its stock trades under the ticker symbol BICX on the OTC.
What does BioCorRx Inc. do?
BioCorRx Inc. is an American Medical Devices company in the Health & Beauty sector.
